News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Bio NC
Tranzyme Pharma Mulls Cash Options to Test Drug
October 14, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DURHAM – The shakedown of the financial markets has forced executives of a local pharmaceutical upstart to redraw their options.
Twitter
LinkedIn
Facebook
Email
Print
MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
·
4 min read
·
Lorenzo Soliman
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
·
3 min read
·
Greg Slabodkin
Job Trends
New Training Models Address Workforce Gap in Biopharma Manufacturing
September 20, 2023
·
4 min read
·
Jennifer Markarian
Business
Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM
January 10, 2023
·
2 min read
·
Lisa Munger
